Giuseppe A. Papalia
Giuseppe A. Papalia publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, on topics such as Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Advanced Biosensing Techniques and Applications.
- World rank
- #558,130 of 7,710,434 ranked researchers
- Rank in United States
- #192,670 of 1,627,098
- Works
- 28
- Citations
- 2.1k
- Citations per work
- 76.8
What does Giuseppe A. Papalia research?
Giuseppe A. Papalia's work is mostly in Biochemistry, Genetics and Molecular Biology (26%), Medicine (25%), Engineering (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1036.9%
- Life Sciences931.0%
- Health Sciences725.0%
- Medicine725.0%
- Physical Sciences27.1%
- Engineering27.1%
- 1Molecular Biology26% of their works
- 2Radiology, Nuclear Medicine and Imaging13% of their works
- 3Infectious Diseases8% of their works
- 4Biomedical Engineering7% of their works
- 5Virology5% of their works
- 6Oncology4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- Advanced Biosensing Techniques and Applications
- HIV Research and Treatment
- HIV/AIDS drug development and treatment
- thermodynamics and calorimetric analyses
- Electrochemical sensors and biosensors
- HIV/AIDS Research and Interventions
Which keywords describe Giuseppe A. Papalia's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Antiretroviral Therapy, Antibody Engineering, Fc Receptors, Biopharmaceuticals, Protein Aggregation and AIDS.
- Preexposure Prophylaxis
- HIV Transmission
- Electrochemical Biosensors
- High-Throughput Analysis
- HIV
- AIDS
- Biopharmaceuticals
- Antibody Engineering
- Therapeutic Antibodies
- Monoclonal Antibodies
- Antiretroviral Therapy
- Fc Receptors
- Protein Aggregation
- Drug Resistance
- HIV Infection
- Protein Microarrays
- Graphene
- Isothermal Titration Calorimetry
- Thermodynamics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies162 topics
- Therapeutic Antibodies162 topics
- Antiretroviral Therapy113 topics
- Antibody Engineering101 topic
- Fc Receptors101 topic
- Biopharmaceuticals61 topic
- Protein Aggregation61 topic
- AIDS41 topic
- Drug Resistance41 topic
- HIV41 topic
- HIV Infection41 topic
- High-Throughput Analysis41 topic
- Protein Microarrays41 topic
- Electrochemical Biosensors31 topic
- Graphene31 topic
- HIV Transmission31 topic
- Isothermal Titration Calorimetry31 topic
- Preexposure Prophylaxis31 topic
- Thermodynamics31 topic
Where does Giuseppe A. Papalia work?
Giuseppe A. Papalia's main affiliation in the publication record is Gilead Sciences (United States), United States.
How many publications and citations does Giuseppe A. Papalia have?
OpenAlex counts 28 works and 2,150 citations for Giuseppe A. Papalia, an h-index of 19, ranking #558,130 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Giuseppe A. Papalia. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.